This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Innovations of Ravi Tejwani
Introduction
Ravi Tejwani is a notable inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations containing pimavanserin. With a total of 3 patents to his name, Tejwani's work has the potential to impact the treatment of various conditions.
Latest Patents
Tejwani's latest patents focus on the formulations of pimavanserin. These patents detail capsules containing pimavanserin, along with the processes for manufacturing these capsules and the pharmaceutical compositions that include this compound. His innovative approach to these formulations showcases his commitment to advancing pharmaceutical science.
Career Highlights
Ravi Tejwani is currently associated with Acadia Pharmaceuticals Inc., where he continues to work on groundbreaking pharmaceutical innovations. His expertise in the field has allowed him to contribute significantly to the development of new therapeutic options.
Collaborations
Tejwani has collaborated with notable professionals in the industry, including Stephen Edward Abele and Emanuel Joseph Vizzotti. These collaborations have further enriched his work and expanded the scope of his innovations.
Conclusion
Ravi Tejwani's contributions to the field of pharmaceuticals, particularly through his patents on pimavanserin formulations, highlight his role as an influential inventor. His ongoing work at Acadia Pharmaceuticals Inc. continues to pave the way for advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile